ARCHIVED - 2009 - Preliminary Results

Warning This page has been archived.

Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

Figure 29. Resistance to antimicrobials in Salmonella isolates from pigs; Surveillance of Animal Clinical Isolates, 2009

Categorization of antimicrobials based on importance in human medicine	Antimicrobial	Pigs (n = 198)
	Antimicrobial	zspecies	bspecies	project	N_ON	ATM	P	LCL	UCL	EBMINUS	EBPLUS
IV
III	Tetracycline	Porcine	Salmonella	Diagnostic / clinical cases	198	TET	0.72222222	0.654	0.783	0.06794	0.06115
	Sulfisoxazole					SSS	0.64141414	0.57	0.708	0.071054	0.06675
	Chloramphenicol					CHL	0.3030303	0.24	0.372	0.063145	0.06915
II	Trimethoprim-sulfamethoxazole					SXT	0.12626263	0.083	0.181	0.042859	0.05446
	Streptomycin					STR	0.6010101	0.529	0.67	0.071827	0.06875
	Nalidixic acid					NAL	0	0	0.015	0	0.01502
	Kanamycin					KAN	0.25757576	0.198	0.324	0.059383	0.0668
	Gentamicin					GEN	0.03535354	0.014	0.071	0.021024	0.03613
	Cefoxitin					FOX	0.03535354	0.014	0.071	0.021024	0.03613
	Ampicillin					AMP	0.41414141	0.345	0.486	0.069382	0.07199
	Amikacin					AMK	0	0	0.015	0	0.01502
I	Ciprofloxacin					CIP	0	0	0.015	0	0.01502
	Ceftriaxone					CRO	0.04040404	0.018	0.078	0.022802	0.03765
	Ceftiofur					TIO	0.04040404	0.018	0.078	0.022802	0.03765
	Amoxicillin-clavulanic acid					AMC	0.03535354	0.014	0.071	0.021024	0.03613

Return to the figure